Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peking University Shougang Hospital is a comprehensive tertiary-level hospital located in the Shijingshan District of Beijing, China. It operates as a joint venture between the state-owned Shougang Group and Peking University, serving as the university's Fourth School of Clinical Medicine. The institution integrates high-level medical care with academic research and medical education, training a significant number of students and residents annually. It is particularly renowned for its clinical excellence in urology, oncology, and cardiovascular diseases, often leading regional healthcare initiatives. As a major clinical trial site, the hospital collaborates with various pharmaceutical and biotech companies to conduct Phase II and III clinical studies. The facility is equipped with advanced diagnostic and therapeutic technologies, supporting its mission to provide integrated healthcare services to the local and national population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peking University Shougang Hospital.